GlassScriptPhysician profile
Kimberly Rau
NPI 1841333283
$14,569.93
in general payments reported to CMS, 2019-2025
36 companies · $2,399 in 2025
The $2,399 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,121 · 2020: $1,186 · 2021: $2,169 · 2022: $1,986 · 2023: $2,849 · 2024: $1,859 · 2025: $2,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,000 · Consulting Fee: $1,000 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,999.70 |
| Consulting Fee | $1,000.00 |
| Education | $107.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,546.42 | 2019-2025 | Tremfya, Simponi, Stelara |
| Abbvie INC. | $1,198.76 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $1,194.82 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $1,129.63 | 2019-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $1,070.94 | 2019-2025 | |
| Pfizer INC. | $1,001.25 | 2019-2025 | |
| Galderma Laboratories, L.P. | $935.17 | 2019-2025 | Nemluvio, Aklief, Epsolay |
| Genzyme Corporation | $673.45 | 2020-2025 | |
| Amgen INC. | $650.47 | 2019-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $592.51 | 2019-2025 | Winlevi, Odomzo, Blu-U |
| Lilly USA, LLC | $573.18 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $513.28 | 2022-2025 | Sotyktu |
| Incyte Corporation | $449.22 | 2021-2025 | Opzelura |
| Ucb, INC. | $354.64 | 2019-2025 | Bimzelx, Cimzia |
| Mayne Pharma Commercial LLC | $347.99 | 2019-2025 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Rau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.